The present study establishes mechanistic connections among metabolic enzymes, metabolites, and the malignant phenotype of cancer cells, and further develops novel pharmacological tools against OC by the induction of DHRS2 and targeting the CHKα/choline metabolic pathway. This evidence concerns the gene CHKA and cancer.